ADAM10 and neoplasm: To further validate whether ADAM10 could reduce EphA3 phosphorylation by cleaving ephrin-A5 to promote tumor progression in vivo, subcutaneous xenograft models were established using DU145-ADAM10, DU145-shRNA2, and their control cells in nude mice.